Search for: "WATSON PHARMACEUTICALS "
Results 1 - 20
of 360
Sort by Relevance
|
Sort by Date
19 Feb 2024, 12:55 pm
Watson, 188 F. [read post]
2 Nov 2023, 8:32 pm
Related StoriesFDA Approves Sandoz Biosimilar for Tysabri®Solicitor General Files Brief Advocating Certiorari Grant in Teva Pharmaceuticals v. [read post]
17 Jan 2023, 6:30 am
Watson Labs., Inc. [read post]
17 Jan 2023, 6:30 am
Watson Labs., Inc. [read post]
17 Jan 2023, 6:30 am
Watson Labs., Inc. [read post]
29 Aug 2022, 9:05 pm
Since President Biden issued his July 2021 Executive Order on Competition, the antitrust agencies have made broad policy statements promising more aggressive enforcement and have initiated a number of high-profile enforcement actions. [read post]
3 May 2022, 1:55 am
Key Findings Federal policymakers are debating a legislative package focused on boosting U.S. competitiveness vis-a-vis China; however, it currently contains little to no improvements to the U.S. tax code. [read post]
28 Dec 2021, 9:42 am
Barry BuchmanMichael ScanlonAs I have noted in prior posts on this site (most recently here), the so-called “bump up” exclusion in D&O insurance policies is a frequent source of coverage litigation between D&O insurance policyholders and their insurers. [read post]
6 Oct 2021, 2:01 pm
Note: The following is the testimony of Dr. [read post]
19 Apr 2021, 9:37 am
Insurance broker Aon has offered to sell assets in several EU countries and the reinsurance unit of takeover target Willis Towers Watson to gain EU antitrust approval for its $30 billion acquisition bid, a person familiar with the matter said on Monday. [read post]
19 Mar 2021, 6:37 am
” Our software will ensure patients receive not only the best treatment possible but personalized pharmaceutical and treatment plans benchmarked using data, rather than depending on the individual experience of a particular physician or group. [read post]
13 Jul 2020, 12:05 pm
As my colleague Garrett Watson argued earlier today, former Vice President Joe Biden’s proposal for strengthening domestic R&D should include making immediate expensing for R&D permanent, instead of letting it expire in 2022. [read post]
16 Jun 2020, 9:59 pm
Watson Laboratories Inc. and Galderma Laboratories, L.P. v. [read post]
18 Nov 2019, 4:24 am
In recent lawsuits, the defendants have included McKesson Corporation, Cardinal Health, AmerisourceBergen, Purdue Pharma, Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson), Endo International, Teva Pharmaceutical, Allergan (formerly Actavis), Watson Pharmaceuticals, Covidien, Johnson & Johnson, CVS, Walgreens, and Rite Aid. [read post]
21 Jun 2019, 3:00 am
Legal Fight Tougher for Congressman as Wife Pleads Guilty AP News – Julie Watson | Published: 6/13/2019 Indicted U.S. [read post]
27 Mar 2019, 1:00 am
Pharmaceutical Pricing Jaime King, University of California Hastings College of the Law, The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs Marc Rodwin, Suffolk University Law School, Controlling Pharmaceutical Prices: What the U.S. [read post]
4 Dec 2018, 2:00 am
Europe continues to have lower trend due to the influence of the integrated government health systems and their ability to negotiate lower pharmaceutical costs. [read post]
17 Nov 2018, 12:10 pm
“Then time will tell just who fellAnd who’s been left behind” Dylan, “Most Likely You Go Your Way” (1966) When the Daubert case headed to the Supreme Court, it had 22 amicus briefs in tow. [read post]
27 Apr 2018, 11:56 am
The existing creative computers he discusses are all narrow or specific AI systems that are programmed to solve particular problems, like systems from the 1980s that were programmed to design new microchips based on certain rules and IBM’s Watson, which is currently identifying novel drug targets for pharmaceutical research. [read post]
14 Apr 2018, 11:46 am
Watson Labs., Inc. [read post]
